Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.
Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, O&N2, Herestraat 49, Bus 921, 3000, Leuven, Belgium.
Arch Toxicol. 2019 May;93(5):1169-1186. doi: 10.1007/s00204-019-02437-2. Epub 2019 Apr 10.
Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-induced cholestatic liver toxicity is a complex process, as it can be triggered by a variety of factors that induce 2 types of biological responses, namely a deteriorative response, caused by bile acid accumulation, and an adaptive response, aimed at removing the accumulated bile acids. Several key events in both types of responses have been characterized in the past few years. In parallel, many efforts have focused on the development and further optimization of experimental cell culture models to predict the occurrence of drug-induced cholestatic liver toxicity in vivo. In this paper, a state-of-the-art overview of mechanisms and in vitro models of drug-induced cholestatic liver injury is provided.
胆汁淤积是药物性肝损伤的主要表现之一。药物性胆汁淤积性肝毒性是一个复杂的过程,因为它可能由多种诱导两种生物反应的因素引发,即胆汁酸蓄积引起的恶化反应和旨在清除蓄积胆汁酸的适应性反应。在过去的几年中,已经对这两种反应中的几个关键事件进行了描述。与此同时,许多研究都致力于开发和进一步优化实验细胞培养模型,以预测体内药物性胆汁淤积性肝毒性的发生。本文对药物性胆汁淤积性肝损伤的机制和体外模型进行了最新综述。